JP2012532197A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532197A5
JP2012532197A5 JP2012519634A JP2012519634A JP2012532197A5 JP 2012532197 A5 JP2012532197 A5 JP 2012532197A5 JP 2012519634 A JP2012519634 A JP 2012519634A JP 2012519634 A JP2012519634 A JP 2012519634A JP 2012532197 A5 JP2012532197 A5 JP 2012532197A5
Authority
JP
Japan
Prior art keywords
oral pharmaceutical
hours
pharmaceutical formulation
compound
retinoid compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012519634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532197A (ja
JP5860398B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/040983 external-priority patent/WO2011003103A2/en
Publication of JP2012532197A publication Critical patent/JP2012532197A/ja
Publication of JP2012532197A5 publication Critical patent/JP2012532197A5/ja
Application granted granted Critical
Publication of JP5860398B2 publication Critical patent/JP5860398B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012519634A 2009-07-02 2010-07-02 視覚サイクルモジュレーターの薬理 Active JP5860398B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22287509P 2009-07-02 2009-07-02
US61/222,875 2009-07-02
US26692209P 2009-12-04 2009-12-04
US61/266,922 2009-12-04
PCT/US2010/040983 WO2011003103A2 (en) 2009-07-02 2010-07-02 Pharmacology of visual cycle modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015247328A Division JP6118886B2 (ja) 2009-07-02 2015-12-18 視覚サイクルモジュレーターの薬理

Publications (3)

Publication Number Publication Date
JP2012532197A JP2012532197A (ja) 2012-12-13
JP2012532197A5 true JP2012532197A5 (enExample) 2013-08-22
JP5860398B2 JP5860398B2 (ja) 2016-02-16

Family

ID=43411786

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012519634A Active JP5860398B2 (ja) 2009-07-02 2010-07-02 視覚サイクルモジュレーターの薬理
JP2015247328A Active JP6118886B2 (ja) 2009-07-02 2015-12-18 視覚サイクルモジュレーターの薬理

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015247328A Active JP6118886B2 (ja) 2009-07-02 2015-12-18 視覚サイクルモジュレーターの薬理

Country Status (5)

Country Link
US (3) US10471027B2 (enExample)
EP (2) EP4000610A1 (enExample)
JP (2) JP5860398B2 (enExample)
ES (1) ES2897527T3 (enExample)
WO (1) WO2011003103A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2541430C2 (ru) 2007-10-05 2015-02-10 Акусела Инк. Композиции и способы лечения нейродегенеративных заболеваний
EP4000610A1 (en) * 2009-07-02 2022-05-25 Acucela Inc. Pharmacology of visual cycle modulators
HK1210969A1 (en) * 2012-01-20 2016-05-13 奥克塞拉有限公司 Substituted heterocyclic compounds for disease treatment
TW201406707A (zh) 2012-05-04 2014-02-16 Acucela Inc 用以治療糖尿病性視網膜病變及其他眼部疾病之方法
CA2903483A1 (en) 2013-03-12 2014-10-09 Acucela Inc. Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
GB884663A (en) 1958-11-06 1961-12-13 Ciba Ltd New amines and processes for their manufacture
CH396941A (de) 1959-08-10 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
GB1145278A (en) 1964-07-07 1969-03-12 Wellcome Found Amidine derivatives, processes for their preparation, and compositions incorporating them
GB1200886A (en) 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
JPS50112386A (enExample) 1974-02-27 1975-09-03
DE2710997C3 (de) 1977-03-14 1980-08-14 Dr. Karl Thomae Gmbh, 7950 Biberach 4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel
JPS6025958A (ja) 1983-07-21 1985-02-08 Kowa Co 新規アミノアルキル置換ベンゼン誘導体
JPH0228112A (ja) * 1988-04-21 1990-01-30 Kaken Pharmaceut Co Ltd 点眼用眼圧調整剤
US5135955A (en) 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
IT1240427B (it) 1990-03-02 1993-12-15 Ministero Dall Uni E Della Ric Arilpropilammine ad azione antifungina
DE4035961A1 (de) 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69224861T2 (de) 1991-07-30 1998-08-06 Korea Res Inst Chem Tech Neue Phenylacetamidderivate und Verfahren zu ihrer Herstellung
WO1993015045A1 (en) 1992-01-29 1993-08-05 Smithkline Beecham Corporation N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
CA2181581A1 (en) 1994-01-19 1995-07-20 Jan Bron Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
US5475034A (en) 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
JP2007008957A (ja) 1994-08-22 2007-01-18 Mitsubishi Pharma Corp ベンゼン化合物およびその医薬としての用途
US5541228A (en) 1994-10-14 1996-07-30 Bristol-Myers Squibb Co. Melatonergic agents
CA2159759A1 (en) 1994-10-14 1996-04-15 Katherine S. Takaki Melatonergic agents
US5631280A (en) 1995-03-29 1997-05-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL117580A0 (en) 1995-03-29 1996-07-23 Merck & Co Inc Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
AU723349B2 (en) 1996-06-07 2000-08-24 Nps Pharmaceuticals, Inc. Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE19643592A1 (de) 1996-10-22 1998-04-23 Bayer Ag Verfahren zur Herstellung von alpha-Alkoxy-alpha-trifluormethyl-arylessigsäureestern und -arylessigsäuren
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6051605A (en) 1997-08-08 2000-04-18 Warner-Lambert Company Method of treating psychosis and schizophrenia
EP1020441A4 (en) 1997-09-11 2002-02-20 Kureha Chemical Ind Co Ltd N-HETEROCYCLIC METHYL PROPYLAMINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND GERMIZIDE
US6171837B1 (en) 1997-09-29 2001-01-09 The Trustees Of Columbia University In The City Of New York Mouse and human 9-cis-retinol dehydrogenase
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
JP2001031636A (ja) 1999-05-18 2001-02-06 Senju Pharmaceut Co Ltd α−ケトアミド誘導体およびその医薬用途
CA2393466C (en) 1999-12-21 2010-01-19 Gpi Nil Holdings, Inc. Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
JP2003342261A (ja) 2000-05-09 2003-12-03 Kureha Chem Ind Co Ltd N−ヘテロ環メチル−アルキルアミン誘導体、その製造方法、および殺菌剤
MXPA02011921A (es) 2000-05-30 2003-04-22 Guilford Pharm Inc Inhibidores de dipeptidasa acida n-acetilada-alfa-enlazada para el tratamiento de trastornos retinianos y glaucona.
US20030032078A1 (en) 2001-01-23 2003-02-13 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of macular and retinal degenerations
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
DE10235312A1 (de) 2002-08-01 2004-02-12 Basf Ag Verfahren zur Herstellung von Aminoalkoxybenzylaminen und Aminoalkoxybenzonitrilen als Zwischenprodukte
WO2004082622A2 (en) 2003-03-14 2004-09-30 University Of Washington Retinoid replacements and opsin agonists and methods for the use thereof
KR20110140139A (ko) 2003-08-29 2011-12-30 오노 야꾸힝 고교 가부시키가이샤 S1p 수용체 결합능을 갖는 화합물 및 그 의약 용도
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
KR20070011379A (ko) * 2004-03-17 2007-01-24 라스 미카엘 라르센 시각 사이클 억제에 의한 망막증의 예방
WO2006091796A2 (en) 2005-02-22 2006-08-31 Acucela, Inc. Compositions and methods for diagnosing and treating retinal diseases
WO2006105215A2 (en) 2005-03-28 2006-10-05 Acucela, Inc. The use of a spin trap for enhancing retinal cell survival and treating retinal degenerative diseases
TW200716110A (en) 2005-04-20 2007-05-01 Smithkline Beecham Corp Inhibitors of AKT activity
TW200744567A (en) 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
EP1973868B1 (en) 2006-01-13 2015-09-09 McGill University Novel elatonin ligands having antidepressant activity as well as sleep inducing properties
WO2007120528A2 (en) 2006-03-31 2007-10-25 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
RU2470910C9 (ru) * 2007-06-29 2013-05-20 Акьюсела, Инк. Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств
RU2541430C2 (ru) 2007-10-05 2015-02-10 Акусела Инк. Композиции и способы лечения нейродегенеративных заболеваний
EP4000610A1 (en) * 2009-07-02 2022-05-25 Acucela Inc. Pharmacology of visual cycle modulators
TW201406707A (zh) * 2012-05-04 2014-02-16 Acucela Inc 用以治療糖尿病性視網膜病變及其他眼部疾病之方法

Similar Documents

Publication Publication Date Title
JP2011502997A5 (enExample)
JP2016512248A5 (enExample)
JP2015504871A5 (enExample)
JP2011511789A5 (enExample)
JP2013525444A5 (enExample)
JP2013526544A5 (enExample)
JP2010077141A5 (enExample)
JP2015503593A5 (enExample)
JP2014500861A5 (enExample)
HRP20171175T1 (hr) Novi triciklički spojevi
SG10201407013QA (en) Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
JP2013545785A5 (enExample)
GEP20156351B (en) Glucagon receptor modulator
WO2012116290A3 (en) Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
JP2012502037A5 (enExample)
WO2011118976A3 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
EP1974722A3 (en) Modified dosage forms of tacrolimus
JP2016511753A5 (enExample)
JP2015143248A5 (enExample)
JP2012513416A5 (enExample)
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
JP2012532197A5 (enExample)
JP2014505017A5 (enExample)
NZ603108A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
JP2013518036A5 (enExample)